130 related articles for article (PubMed ID: 19488013)
1. Nitazoxanide and probiotics for the treatment of recurrent Clostridium difficile infection in a peritoneal dialysis patient.
Yangco BG; Sher G; Bardin MC
South Med J; 2009 Jul; 102(7):746-7. PubMed ID: 19488013
[TBL] [Abstract][Full Text] [Related]
2. Best strategies in recurrent or persistent Clostridium difficile infection.
Cocanour CS
Surg Infect (Larchmt); 2011 Jun; 12(3):235-9. PubMed ID: 21767157
[TBL] [Abstract][Full Text] [Related]
3. Clostridioides difficile associated peritonitis in peritoneal dialysis patients - a case series based review of an under-recognized entity with therapeutic challenges.
Shah KJ; Cherabuddi K; Pressly KB; Wright KL; Shukla A
BMC Nephrol; 2020 Mar; 21(1):76. PubMed ID: 32131755
[TBL] [Abstract][Full Text] [Related]
4. Emerging therapies for Clostridium difficile infections.
McFarland LV
Expert Opin Emerg Drugs; 2011 Sep; 16(3):425-39. PubMed ID: 21443387
[TBL] [Abstract][Full Text] [Related]
5. Clostridium difficile colitis that fails conventional metronidazole therapy: response to nitazoxanide.
Musher DM; Logan N; Mehendiratta V; Melgarejo NA; Garud S; Hamill RJ
J Antimicrob Chemother; 2007 Apr; 59(4):705-10. PubMed ID: 17337513
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis and management of Clostridium difficile infection.
Dupont HL
Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1216-23; quiz e73. PubMed ID: 23542332
[TBL] [Abstract][Full Text] [Related]
7. Prevention of Clostridium difficile Infection With Probiotics.
Evans CT; Johnson S
Clin Infect Dis; 2015 May; 60 Suppl 2():S122-8. PubMed ID: 25922397
[TBL] [Abstract][Full Text] [Related]
8. The evaluation of Clostridium difficile infection (CDI) in a community hospital.
Daniel A; Rapose A
J Infect Public Health; 2015; 8(2):155-60. PubMed ID: 25301221
[TBL] [Abstract][Full Text] [Related]
9. Alternative therapies for Clostridium difficile infections.
Venuto C; Butler M; Ashley ED; Brown J
Pharmacotherapy; 2010 Dec; 30(12):1266-78. PubMed ID: 21114394
[TBL] [Abstract][Full Text] [Related]
10. Nitazoxanide versus vancomycin in Clostridium difficile infection: a randomized, double-blind study.
Musher DM; Logan N; Bressler AM; Johnson DP; Rossignol JF
Clin Infect Dis; 2009 Feb; 48(4):e41-6. PubMed ID: 19133801
[TBL] [Abstract][Full Text] [Related]
11. Challenges and opportunities in the management of Clostridium difficile infection.
DuPont HL
Expert Rev Gastroenterol Hepatol; 2014 Nov; 8(8):863-74. PubMed ID: 25012255
[TBL] [Abstract][Full Text] [Related]
12. Is primary prevention of Clostridium difficile infection possible with specific probiotics?
Johnson S; Maziade PJ; McFarland LV; Trick W; Donskey C; Currie B; Low DE; Goldstein EJ
Int J Infect Dis; 2012 Nov; 16(11):e786-92. PubMed ID: 22863358
[TBL] [Abstract][Full Text] [Related]
13. European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection.
Debast SB; Bauer MP; Kuijper EJ;
Clin Microbiol Infect; 2014 Mar; 20 Suppl 2():1-26. PubMed ID: 24118601
[TBL] [Abstract][Full Text] [Related]
14. Whole-genome sequencing improves discrimination of relapse from reinfection and identifies transmission events among patients with recurrent Clostridium difficile infections.
Mac Aogáin M; Moloney G; Kilkenny S; Kelleher M; Kelleghan M; Boyle B; Rogers TR
J Hosp Infect; 2015 Jun; 90(2):108-16. PubMed ID: 25935700
[TBL] [Abstract][Full Text] [Related]
15. Clostridium difficile: controversies and approaches to management.
Bauer MP; van Dissel JT; Kuijper EJ
Curr Opin Infect Dis; 2009 Dec; 22(6):517-24. PubMed ID: 19738464
[TBL] [Abstract][Full Text] [Related]
16. Probiotics for Prevention and Treatment of Clostridium difficile Infection.
Valdés-Varela L; Gueimonde M; Ruas-Madiedo P
Adv Exp Med Biol; 2018; 1050():161-176. PubMed ID: 29383669
[TBL] [Abstract][Full Text] [Related]
17. Rifaximin for the treatment of recurrent Clostridium difficile infection after liver transplantation: A case series.
Neff G; Zacharias V; Kaiser TE; Gaddis A; Kemmer N
Liver Transpl; 2010 Aug; 16(8):960-3. PubMed ID: 20677286
[TBL] [Abstract][Full Text] [Related]
18. Successful use of nitazoxanide in the treatment of recurrent Clostridium difficile infection.
Rafiullah F; Kanwal S; Majeed UM; Korsten MA; Cheema FH; Luthra M; Sohail MR
BMJ Case Rep; 2011 Nov; 2011():. PubMed ID: 22674696
[TBL] [Abstract][Full Text] [Related]
19. Fecal bacteriotherapy for relapsing Clostridium difficile infection in a child: a proposed treatment protocol.
Russell G; Kaplan J; Ferraro M; Michelow IC
Pediatrics; 2010 Jul; 126(1):e239-42. PubMed ID: 20547640
[TBL] [Abstract][Full Text] [Related]
20. Assessment of treatment patterns and patient outcomes before vs after implementation of a severity-based Clostridium difficile infection treatment policy.
Jardin CG; Palmer HR; Shah DN; Le F; Beyda ND; Jiang Z; Garey KW
J Hosp Infect; 2013 Sep; 85(1):28-32. PubMed ID: 23834988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
